Evogene Ltd.
EVGN- Exchange
- Nasdaq
- Industry
- Agricultural Chemicals
- SEC CIK
- 0001574565
In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Evogene Ltd. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 15 | 13 | −2 |
| Shares | 530.6K | 282.1K | −248.5K (−46.8%) |
| Value | $408.9K | $120.0K | −$288.9K (−70.6%) |
New holders (3)
Institutions that held Evogene Ltd. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 107,198 | $45.0K | 0.00% |
| Susquehanna International Group, LLP | 80,078 | $33.9K | 0.00% |
| Citadel Advisors LLC | 50,526 | $21.4K | 0.00% |
Sold out (5)
Institutions that held Evogene Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Armistice Capital, LLC | 456,587 | $351.6K |
| Jane Street Group, LLC | 18,500 | $14.2K |
| Two Sigma Securities, LLC | 12,465 | $9.60K |
| Steward Partners Investment Advisory, LLC | 505 | $389 |
| Tradewinds Capital Management, LLC | 131 | $101 |